Cargando…
Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects
Apatinib is an oral tyrosine kinase inhibitor, which selectively targets vascular endothelial growth factor receptor 2 and has the potential to treat many tumors therapeutically. Cyclic arginylglycylaspartic acid (cRGD)- and polyethylene glycol (PEG)-modified liposomes (cRGD-Lipo-PEG) were construct...
Autores principales: | Song, Zhiwang, Lin, Yun, Zhang, Xia, Feng, Chan, Lu, Yonglin, Gao, Yong, Dong, Chunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354530/ https://www.ncbi.nlm.nih.gov/pubmed/28331317 http://dx.doi.org/10.2147/IJN.S125573 |
Ejemplares similares
-
Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
por: Chen, Zhongya, et al.
Publicado: (2012) -
Size‐Dependent Cellular Uptake of RGD Peptides
por: Kemker, Isabell, et al.
Publicado: (2019) -
RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer
por: Feng, Chan, et al.
Publicado: (2015) -
Targeted Delivery of FLT-Morpholino Using Cyclic RGD Peptide
por: Uehara, Hironori, et al.
Publicado: (2017) -
Polycondensed Peptide Carriers Modified with Cyclic RGD Ligand for Targeted Suicide Gene Delivery to Uterine Fibroid Cells
por: Egorova, Anna, et al.
Publicado: (2022)